MIXTARD 30/70 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

mixtard 30/70 penfill human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 70 iu/ml; insulin, quantity: 30 iu/ml - injection, suspension - excipient ingredients: protamine sulfate; dibasic sodium phosphate dihydrate; hydrochloric acid; glycerol; zinc chloride; sodium hydroxide; metacresol; water for injections; phenol - the treatment of insulin-requiring diabetes.

MIXTARD 30/70 INNOLET human insulin (rys) 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

mixtard 30/70 innolet human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 30 iu/ml; insulin, quantity: 70 iu/ml - injection, suspension - excipient ingredients: glycerol; protamine sulfate; phenol; metacresol; hydrochloric acid; dibasic sodium phosphate dihydrate; zinc chloride; water for injections; sodium hydroxide - the treatment of insulin-requiring diabetes.

ACTRAPID human insulin (rys) 100IU/mL injection multidose vial Australia - English - Department of Health (Therapeutic Goods Administration)

actrapid human insulin (rys) 100iu/ml injection multidose vial

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; glycerol; hydrochloric acid; zinc chloride; water for injections; sodium hydroxide - the treatment of insulin-requiring diabetes.

ACTRAPID PENFILL human insulin (rys) 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

actrapid penfill human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; sodium hydroxide; glycerol; hydrochloric acid; water for injections; zinc chloride - the treatment of insulin-requiring diabetes.

APIDRA SOLOSTAR insulin glulisine (rbe) 100IU/mL 3mL solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

apidra solostar insulin glulisine (rbe) 100iu/ml 3ml solution for injection injector pen

sanofi-aventis australia pty ltd - insulin glulisine, quantity: 3.49 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; metacresol; polysorbate 20; trometamol; hydrochloric acid; sodium hydroxide - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.

HUMULIN R biosynthetic human neutral insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin r biosynthetic human neutral insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; metacresol; hydrochloric acid; glycerol - other conditions: refrigerate - do not freeze. indications: for the treatment of insulin dependent diabetic patients.

HUMULIN R insulin 100IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin r insulin 100iu/ml injection vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; glycerol; water for injections; hydrochloric acid; sodium hydroxide - indications as at 05 feb 2002 : humulin is indicated for the treatment of insulin - dependant diabetic patients.

TOUJEO Israel - English - Ministry of Health

toujeo

sanofi israel ltd - insulin glargine - solution for injection - insulin glargine 300 u/ml - insulin glargine - treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years .

TOUJEO MAX SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

toujeo max solostar insulin glargine 300 units/ml solution for injection injector pen

sanofi-aventis australia pty ltd - insulin glargine, quantity: 32.74 mg - injection, solution - excipient ingredients: metacresol; zinc chloride; glycerol; sodium hydroxide; hydrochloric acid; water for injections - treatment of diabetes mellitus in adults

LANTUS- insulin glargine injection, solution United States - English - NLM (National Library of Medicine)

lantus- insulin glargine injection, solution

a-s medication solutions - insulin glargine (unii: 2zm8cx04rz) (insulin glargine - unii:2zm8cx04rz) - insulin glargine 100 [iu] in 1 ml - lantus is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. limitations of use lantus is not recommended for the treatment of diabetic ketoacidosis. lantus is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] - in patients with hypersensitivity to insulin glargine or any of the excipients in lantus [see warnings and precautions (5.5)] risk summary published studies with use of insulin glargine during pregnancy have not reported a clear association with insulin glargine and adverse developmental outcomes (see data) . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . rats and rabbits were exposed to insulin glargine in animal reproduction studies during organogenesis, respectively 50 times and 10 times the human subcutaneous dosage of 0.2 units/kg/day. overall, the effects of insulin glargine did not generally differ from those observed with regular huma